Janney Montgomery Scott
CODX

Janney Montgomery Scott’s Co-Diagnostics CODX Stock Holding History

Janney Montgomery Scott’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-457
Closed -$44K – 2579
2022
Q3 		$44K Sell
457
-110
-19% -$15.4K ﹤0.01% 2454
2022
Q2 		$87K Sell
567
-602
-51% -$91.6K ﹤0.01% 2253
2022
Q1 		$217K Sell
1,169
-97
-8% -$20.1K ﹤0.01% 2042
2021
Q4 		$339K Buy
1,266
+589
+87% +$155K ﹤0.01% 1939
2021
Q3 		$198K Buy
+677
New +$198K ﹤0.01% 2167

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Janney Montgomery Scott's CODX Position: Q4 2022 in Review

Janney Montgomery Scott sold out of Co-Diagnostics (CODX) in Q4 2022, closing a stake of 457 shares — an estimated $44K sold.

Janney Montgomery Scott first reported a position in CODX in Q3 2021 and held it in 5 quarters. The position peaked at $339K in Q4 2021. 60 funds tracked by Wall St. Rank hold CODX as of Q4 2022.

  • Janney Montgomery Scott reported no remaining Co-Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Janney Montgomery Scott sold 457 Co-Diagnostics shares in Q4 2022, an estimated $44K.
  • Janney Montgomery Scott first reported a position in Co-Diagnostics in Q3 2021 and held it in 5 quarters.
  • Janney Montgomery Scott's Co-Diagnostics position peaked at $339K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2022.

Based on Janney Montgomery Scott's 13F filing for Q4 2022, filed 1 Feb 2023.